Fibrocell and Intrexon Announce IND Filing of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
July 20, 2015 at 08:08 AM EDT
Fibrocell Science, Inc., (NASDAQ: FCSC), an autologous cell and gene therapy company focused on developing first-in-class treatments for ...
